The Potts Memorial Foundation focuses tightly on biomedical research to prevent and treat tuberculosis, funding laboratory science, drug/target validation, and investigator support (including post‑doctoral fellowships). Grants go primarily to university medical schools and research institutes across the U.S., with occasional support for TB awareness events like World Tuberculosis Day. The foundation favors hypothesis‑driven immunology, microbiology, and pharmacologic studies aimed at new solutions to persistent TB problems.
Potts Memorial Foundation’s giving is centered on tuberculosis research, and its recent awards show a consistent emphasis on laboratory science, investigator support, and preclinical target validation. The foundation has backed multiple projects at Weill Cornell Medical College, including a 2025 postdoctoral fellowship for TB research and a 2024 study on the transmission biology of M. tuberculosis. It has also supported work at institutions such as Albert Einstein College of Medicine, Rutgers NJ Medical School Public Health Research Institute, and the Trudeau Institute, all tied to questions about persistence, immune response, or new drug targets. The foundation’s grantmaking reaches both basic and translational TB work. Recent awards include support for macrophage biology and gluconeogenesis in latency, myeloid-derived suppressor cells in the immune response to Mycobacterium tuberculosis, and in vivo validation of a novel TB drug target. Alongside research grants, it has also funded World Tuberculosis Day activities and workforce-related support for certified respiratory therapists. The pattern points to a funder that supports scientific inquiry, early-career researchers, and selected public awareness or training efforts within the TB field.
In TB pathogenesis and persistence research, Potts Memorial Foundation supported Weill Cornell Medical College with $61,875 in 2023 for studying macrophages and gluconeogenesis in the regulation of Mycobacterium tuberculosis persistence in a mouse model of latency, and later gave $50,000 in 2024 for insights into the transmission biology of M. tuberculosis. On immune mechanisms, the foundation awarded $50,000 to the University of Georgia for evaluating myeloid-derived suppressor cells in the immune response to Mycobacterium tuberculosis, and $25,000 to Johns Hopkins University School of Medicine for work on the RNA sensor LGP2 during TB infection. Its vaccine and drug-focused support includes $33,000 to Albany Medical College Dept of Immunology & Microbial Disease for secretion mechanism of c-di-AMP by Mycobacterium tuberculosis and its impact on BCG vaccine efficacy, plus $25,000 to Trudeau Institute for in vivo validation of a novel Mycobacterium tuberculosis drug target, ASPC.
$293K
$5.6M
$554K
$358K
Most grants fall between $25K and $50K, with a median of $30K.
25th Percentile
$25K
Median
$30K
75th Percentile
$50K
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Concentrated, mission‑driven giving to academic medical centers and research labs; a mix of several mid‑to‑large grants and repeat funding to core grantees (notably multi‑year support to Weill Cornell), rather than many small or broadly distributed community grants.
Notable grantees: Weill Cornell Medical College, Rutgers NJ Medical School Public Health Research Institute, Albert Einstein College of Medicine, University of Georgia (research on myeloid cells in TB), Albany Medical College Dept. of Immunology & Microbial Disease
Typical grant size is $25,000 at the 25th percentile, $30,000 at the median, and $50,000 at the 75th percentile. The 2025 filings show both research grants and smaller support awards, including a postdoctoral fellowship and stipend for TB research. Recent awards also show repeated support to the same institutions across multiple years, especially Weill Cornell Medical College and Trudeau Institute, which suggests ongoing relationships rather than one-off gifts. Potts Memorial Foundation is not a program-related-investment funder.
Potts Memorial Foundation gives mainly in New York, which accounts for 70% of recipients in the foundation’s grant data. Recent New York recipients include New York City, Bronx, Albany, Saratoga-area Saranac Lake, and Hudson. Outside New York, the foundation has also funded grantees in Athens, GA; Newark, NJ; Worcester, MA; Boston, MA; Baltimore, MD; and Menands, NY. All listed recent grants in the dataset go to U.S. recipients.
Its recent awards cover TB persistence, transmission biology, immune mechanisms, drug and target validation, vaccine-related research, and selected public awareness or workforce-support activities. Examples include macrophage biology in latency, myeloid-derived suppressor cells, c-di-AMP and BCG vaccine efficacy, and a novel drug target called ASPC.
Yes. In 2025 it gave $60,000 to Weill Cornell Medical College for a postdoctoral fellowship for TB research, and another $52,500 there for a TB research stipend. The foundation’s grant pattern also includes recurring support for research institutions working on tuberculosis.
The foundation’s grant-size distribution is $25,000 at the 25th percentile, $30,000 at the median, and $50,000 at the 75th percentile. Recent awards include both research grants and smaller support awards, with several grants clustered in that range.
New York is the top state by grant count, with 70% of grants going to recipients in NY. Recent New York recipients include institutions in New York City, the Bronx, Albany, Saranac Lake, Hudson, and Menands.
2026
Source: IRS Form 990-PF, fiscal year 2026.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| TRUSTEES OF TUFTS UNIVERSITY | BOSTON, MA | $50,000 | 2026 | RESEARCH UNDERSTANDING REGULATION OF CALCIUM-MEDIATED EFFECTS ON MYCOBACTERIUM TUBERCULOSIS GROWTH. |
| THE ROCKEFELLER UNIVERSITY | NEW YORK, NY | $50,000 | 2026 | RESEARCH PEBBLE: SUSTAINING AND EXPANDING A CRITICAL RESOURCE FOR CRISPR-BASED FUNCTIONAL GENOMICS IN MYCOBACTERIA |
| WEILL CORNELL MEDICAL COLLEGE | NEW YORK, NY | $37,000 | 2026 | RESEARCH GENIC NETWORKS THAT PREVENT KILLING OF MYCOBACTERIUM TUBERCULOSIS BY ATP SYNTHASE INHIBITORS |
| TRUSTEES OF COLUMBIA UNIVERSITY | NEW YORK, NY | $36,000 | 2026 | RESEARCH EARLY HOST BIOMARKERS OF CLINICAL OUTCOMES IN MDR-TB AND HIV CO-INFECTION USING OLINK PROTEOMICS |
| TRUDEAU INSTITUTE | SARANAC LAKE, NY | $25,000 | 2026 | SUPPORT THE NORTHEAST REGIONAL WORLD TB DAY CONFERENCE. |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE | BALTIMORE, MD | $25,000 | 2026 | RESEARCHING THE ELIMINATION OF SENESCENT CELLS WITH SENOLYTIC HOST-DIRECTED THERAPY REDUCES TUBERCULOSIS PROGRESSION IN SUSCEPTIBLE MOUSE MODELS. |
| WASHINGTON UNIVERSITY SCHOOL OF MEDICINE | ST LOUIS, MO | $25,000 | 2026 | RESEARCH THE NONCANONICAL AND RAPID IFN-1 INDUCTION BY NEUTROPHILS IN RESPONSE TO MYCOBACTERIUM TUBERCULOSIS. |
| UMASS CHAN MEDICAL SCHOOL | WORCESTER, MA | $25,000 | 2026 | RESEARCH UNDERSTANDING THE ROLE OF HIGH-FREQUENCY GENETIC VARIATION IN TUBERCULOSIS TREATMENT FAILURE |
| WEILL CORNELL MEDICAL COLLEGE | NEW YORK, NY | $20,000 | 2026 | RESEARCH OF POST-TUBERCULOSIS LUNG DISEASE IN PEOPLE LIVING WITH HIV: MATRIX METALLOPROTEINASES AND THE AGE-RAGE AXIS |
| WEILL CORNELL MEDICAL COLLEGE | NEW YORK, NY | $60,000 | 2025 | POST DOC FELLOWSHIP FOR TB RESEARCH |
| WEILL CORNELL MEDICAL COLLEGE | NEW YORK, NY | $52,500 | 2025 | STIPEND FOR TB RESEARCH |
| TRUSTEES OF TUFTS UNIVERSITY | BOSTON, MA | $30,000 | 2025 | EXPLORING THE ROLE OF CALCIUM HOMEOSTASIS IN MTB |
| WORCESTER POLYTECHNIC INSTITUTE | WORCESTER, MA | $30,000 | 2025 | THE ROLE OF TRPG IN ARTEMISININ ACTIVITY |
| TRUDEAU INSTITUTE | SARANAC LAKE, NY | $30,000 | 2025 | TARGET VALIDATION AND PHARMACOKINETIC EVALUATION OF RAPIDLY TUBERCULOCIDAL COMPOUNDS |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE | BALTIMORE, MD | $25,000 | 2025 | RNA SENSOR LGP2 AND ITS ROLE DURING TB INFECTION |
| TRUSTEES OF COLUMBIA UNIVERSITY | NEW YORK, NY | $20,702 | 2025 | USE OF XPERT MTB/RIF ULTRA AND NOVEL HIGH DIMENSIONAL PROTEOMICS... |
| HEALTH RESEARCH INC | MENANDS, NY | $15,520 | 2025 | WORLD TB DAY SUPPORT |
| WEILL CORNELL MEDICAL COLLEGE | NEW YORK, NY | $50,000 | 2024 | INSIGHTS INTO THE TRANSMISSION BIOLOGY OF M. TUBERCULOSIS |
| RUTGERS NJ MEDICAL SCHOOL PUBLIC HEALTH RESEARCH INSTITUTE | NEWARK, NJ | $47,560 | 2024 | INVESTIGATION OF IMMUNE MECHANISMS REGULATING HETEROGENEITY |
| WEILL CORNELL MEDICAL COLLEGE | NEW YORK, NY | $46,250 | 2024 | STUDYING THE ROLE OF MACROPHAGES AND GLUCONEOGENESIS IN THE REGULATION OF MYCOBACTERIUM TUBERCULOSIS PERSISTENCE IN A MOUSE MODEL OF LATENCY |
| TRUDEAU INSTITUTE | SARANAC LAKE, NY | $25,000 | 2024 | IN VIVO VALIDATION OF A NOVEL MYCOBACTERIUM TUBERCULOSIS DRUG TARGET, ASPC |
| NYU GROSSMAN MEDICINE | NEW YORK, NY | $25,000 | 2024 | WORLD TUBERCULOSIS DAY SUPPORT |
| COLUMBIA MEMORIAL HEALTH FOUNDATION | HUDSON, NY | $18,500 | 2024 | TO PURCHASE A HAMILTON-C1 PORTABLE VENTILATOR |
| WEILL CORNELL MEDICAL COLLEGE | NEW YORK, NY | $61,875 | 2023 | STUDYING THE ROLE OF MACROPHAGES AND GLUCONEOGENESIS IN THE REGULATION OF MYCOBACTERIUM TUBERCULOSIS PERSISTENCE IN A MOUSE MODEL OF LATENCY |
| ALBERT EINSTEIN COLLEGE OF MEDICINE | BRONX, NY | $50,000 | 2023 | SUPPORTING "PDIM OF M. TUBERCULOSIS NEW SOLUTIONS TO PERSISTENT PROBLEM" |
| UNIVERSITY OF GEORGIA | ATHENS, GA | $50,000 | 2023 | "EVALUATION OF THE ROLE OF MYELOID-DERIVED SUPPRESSOR CELLS IN THE IMMUNE RESPONSE TO MYCOBACTERIUM TUBERCULOSIS" |
| ALBANY MEDICAL COLLEGE DEPT OF IMMUNOLOGY & MICROBIAL DISEASE | ALBANY, NY | $33,000 | 2023 | SECRETION MECHANISM OF C-DI-AMP BY MYCOBACTERIUM TUBERCULOSIS AND THE IMPACT ON EFFICACY OF THE BCG VACCINE |
| RUTGERS NJ MEDICAL SCHOOL PUBLIC HEALTH RESEARCH INSTITUTE | NEWARK, NJ | $25,000 | 2023 | SUPPORTING WORLD TUBERCULOSIS DAY ON 3/23/23 |
| COLUMBIA MEMORIAL HEALTH FOUNDATION | HUDSON, NY | $18,000 | 2023 | SUPPORTING THE "ADVANCING THE WORKFORCE" EDUCATION FUND FOR CERTIFIED RESPIRATORY THERAPISTS. |
TRUSTEES OF TUFTS UNIVERSITY
$50,000RESEARCH UNDERSTANDING REGULATION OF CALCIUM-MEDIATED EFFECTS ON MYCOBACTERIUM TUBERCULOSIS GROWTH.
RESEARCH PEBBLE: SUSTAINING AND EXPANDING A CRITICAL RESOURCE FOR CRISPR-BASED FUNCTIONAL GENOMICS IN MYCOBACTERIA
WEILL CORNELL MEDICAL COLLEGE
$37,000RESEARCH GENIC NETWORKS THAT PREVENT KILLING OF MYCOBACTERIUM TUBERCULOSIS BY ATP SYNTHASE INHIBITORS
TRUSTEES OF COLUMBIA UNIVERSITY
$36,000RESEARCH EARLY HOST BIOMARKERS OF CLINICAL OUTCOMES IN MDR-TB AND HIV CO-INFECTION USING OLINK PROTEOMICS
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
$25,000RESEARCHING THE ELIMINATION OF SENESCENT CELLS WITH SENOLYTIC HOST-DIRECTED THERAPY REDUCES TUBERCULOSIS PROGRESSION IN SUSCEPTIBLE MOUSE MODELS.
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
$25,000RESEARCH THE NONCANONICAL AND RAPID IFN-1 INDUCTION BY NEUTROPHILS IN RESPONSE TO MYCOBACTERIUM TUBERCULOSIS.
UMASS CHAN MEDICAL SCHOOL
$25,000RESEARCH UNDERSTANDING THE ROLE OF HIGH-FREQUENCY GENETIC VARIATION IN TUBERCULOSIS TREATMENT FAILURE
WEILL CORNELL MEDICAL COLLEGE
$20,000RESEARCH OF POST-TUBERCULOSIS LUNG DISEASE IN PEOPLE LIVING WITH HIV: MATRIX METALLOPROTEINASES AND THE AGE-RAGE AXIS
WEILL CORNELL MEDICAL COLLEGE
$60,000POST DOC FELLOWSHIP FOR TB RESEARCH
WEILL CORNELL MEDICAL COLLEGE
$52,500STIPEND FOR TB RESEARCH
TRUSTEES OF TUFTS UNIVERSITY
$30,000EXPLORING THE ROLE OF CALCIUM HOMEOSTASIS IN MTB
TARGET VALIDATION AND PHARMACOKINETIC EVALUATION OF RAPIDLY TUBERCULOCIDAL COMPOUNDS
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
$25,000RNA SENSOR LGP2 AND ITS ROLE DURING TB INFECTION
TRUSTEES OF COLUMBIA UNIVERSITY
$20,702USE OF XPERT MTB/RIF ULTRA AND NOVEL HIGH DIMENSIONAL PROTEOMICS...
WEILL CORNELL MEDICAL COLLEGE
$50,000INSIGHTS INTO THE TRANSMISSION BIOLOGY OF M. TUBERCULOSIS
RUTGERS NJ MEDICAL SCHOOL PUBLIC HEALTH RESEARCH INSTITUTE
$47,560INVESTIGATION OF IMMUNE MECHANISMS REGULATING HETEROGENEITY
WEILL CORNELL MEDICAL COLLEGE
$46,250STUDYING THE ROLE OF MACROPHAGES AND GLUCONEOGENESIS IN THE REGULATION OF MYCOBACTERIUM TUBERCULOSIS PERSISTENCE IN A MOUSE MODEL OF LATENCY
IN VIVO VALIDATION OF A NOVEL MYCOBACTERIUM TUBERCULOSIS DRUG TARGET, ASPC
NYU GROSSMAN MEDICINE
$25,000WORLD TUBERCULOSIS DAY SUPPORT
COLUMBIA MEMORIAL HEALTH FOUNDATION
$18,500TO PURCHASE A HAMILTON-C1 PORTABLE VENTILATOR
WEILL CORNELL MEDICAL COLLEGE
$61,875STUDYING THE ROLE OF MACROPHAGES AND GLUCONEOGENESIS IN THE REGULATION OF MYCOBACTERIUM TUBERCULOSIS PERSISTENCE IN A MOUSE MODEL OF LATENCY
SUPPORTING "PDIM OF M. TUBERCULOSIS NEW SOLUTIONS TO PERSISTENT PROBLEM"
UNIVERSITY OF GEORGIA
$50,000"EVALUATION OF THE ROLE OF MYELOID-DERIVED SUPPRESSOR CELLS IN THE IMMUNE RESPONSE TO MYCOBACTERIUM TUBERCULOSIS"
ALBANY MEDICAL COLLEGE DEPT OF IMMUNOLOGY & MICROBIAL DISEASE
$33,000SECRETION MECHANISM OF C-DI-AMP BY MYCOBACTERIUM TUBERCULOSIS AND THE IMPACT ON EFFICACY OF THE BCG VACCINE
RUTGERS NJ MEDICAL SCHOOL PUBLIC HEALTH RESEARCH INSTITUTE
$25,000SUPPORTING WORLD TUBERCULOSIS DAY ON 3/23/23
COLUMBIA MEMORIAL HEALTH FOUNDATION
$18,000SUPPORTING THE "ADVANCING THE WORKFORCE" EDUCATION FUND FOR CERTIFIED RESPIRATORY THERAPISTS.